Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Alopecia can be linked to autoimmune issues, vitiligo, nail problems, and sometimes cancer treatments.

Zinc supplementation may be an important part of treating severe hair loss.

Hydroxychloroquine may help hair regrowth in alopecia universalis.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

A COVID-19 vaccine may trigger severe hair loss in rare cases.

Oral tofacitinib successfully treated total body hair loss in one patient.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Current treatments for alopecia show no significant long-term benefits.

Low iron levels may be linked to some types of hair loss in women.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.

COVID-19 doesn't make alopecia areata worse.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

Alopecia areata in children shows varied forms and treatment challenges, with some achieving full or partial hair regrowth.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.